By Maria Cook
On May 20, PTS Diagnostics, a U.S.-based medical manufacturer specializing in biometric testing devices, opened its global headquarters in Whitestown. The company, which was previously located at 7736 Zionsville Rd., now boasts a 135,000-square-foot facility at 4600 Anson Blvd. The new property includes a walking trail, fitness center, Zen garden and other amenities for employees.
President and CEO Robert Huffstodt said the Whitestown property’s size and proximity to nature were key factors in the decision to relocate there.
“We looked in Indianapolis but couldn’t find the right property that would give us the flexibility to expand later if needed, and also give us the campus-like feel that we have here with the wooded area adjacent to our HQ building,” Huffstodt said.
Founded in 1992, PTS Diagnostics manufactures and markets products in more than 135 nations. In addition to its Whitestown location, the company maintains a manufacturing facility in Sunnyvale, Calif., and has sales offices in Europe, Latin America and the Pacific Rim. Its former Indiana location on Zionsville Road will remain open for disaster recovery and manufacturing needs.
The company’s biometric testing devices are mainly used to assess patient’s risks for certain diseases or to help determine which treatments will be most effective for individual patients. One of its most well-known products, CardioChek, is used to assess cardiovascular disease risks through lipid panel screening.
PTS Diagnostics has approximately 240 full-time employees domestically and internationally. According to a press release, the opening of the company’s Whitestown facility has led to hiring in research and development, operations and manufacturing. Huffstodt said hiring in key departments is expected to continue for the foreseeable future, and that approximately 12 positions are open.
“Our priorities were to have room to continue to grow while also providing a superior environment for our employees,” Huffstodt said.
